Stem Cells Live: Pharma-Biotech Partnering Snapshot

This morning panel discussion at the 9th WSCRM Conference with Micheal Shuster (Mesoblast), Zami Aberman (Pluristem Therapeutics) and Micheal Hunt (ReNeuron) was an interesting confrontation on how differently-sized regen med companies engage with funding and deal making strategies. Both Mesoblast and Pluristem have years of experience in negotiating solid partnerships (Teva and Lonza the former, United Therapeutics and an other …